Analyze Diet

Antipyrine pharmacokinetics and urinary excretion in female horses.

Abstract: To measure renal clearance of antipyrine and urinary excretion of antipyrine (AP) metabolites in horses by use of validated high-performance liquid chromatography (HPLC) methods. Methods: 8 Standardbred mares. Methods: HPLC methods for measurement of AP in equine plasma and AP and its metabolites in equine urine were validated. Antipyrine (20 mg/kg of body weight) was administered i.v., and blood samples and urine specimens were collected over 24 hours. Results: Median plasma clearance of AP in horses was 6.2 ml/min/kg, of which < 2% could be attributed to renal clearance. Urinary excretion of AP and its metabolites over 24 hours accounted for < 22% of the AP dose administered. The major metabolite of AP in urine was 4-hydroxyantipyrine. Conclusions: Use of the proven validated methods for measuring AP and its metabolites indicated that AP has minimal renal clearance in horses, suggesting that plasma clearance of AP reflects hepatic clearance. Combined with AP metabolite data, the pharmacokinetics of AP may be useful for assessment of hepatic cytochrome P450 activity in horses.
Publication Date: 1998-04-02 PubMed ID: 9522945
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on how female horses metabolize and excrete Antipyrine, with the majority of the drug presumably broken down in the liver, not the kidneys. This information can potentially be used to analyze liver function in horses, particularly regarding an enzyme involved in drug metabolism.

Study Design and Methodology

  • A validated high-performance liquid chromatography (HPLC) method was used to study the pharmacokinetics of Antipyrine (AP) in 8 Standardbred mares. Pharmacokinetics involves understanding how the body absorbs, distributes, metabolizes, and excretes drugs. HPLC is a specialized type of chromatography, a technique for separating the components in a mixture, commonly employed in biochemistry and analytical chemistry.
  • AP, at a rate of 20mg/kg body weight, was injected into these mares. Blood samples and urine specimens were then collected over a span of 24 hours to monitor the levels of AP and its metabolites.

Results and Findings

  • The median plasma clearance of AP was found to be 6.2 ml/min/kg. This is how fast the body eliminates the drug from the bloodstream.
  • Surprisingly, less than 2% of this clearance could be chalked up to renal (kidney) activity. This suggested that the liver played a significant role in AP metabolization.
  • Urinary excretion of AP and its metabolites accounted for less than 22% of the administered AP dose within 24 hours. This further supported the minor role the kidneys played in AP processing.
  • The major metabolite found in urine was 4-hydroxyantipyrine, a byproduct of AP after it has been metabolized.

Conclusions and Implications

  • The research concluded that Antipyrine has minimal renal clearance in horses, implying that the plasma clearance of AP is largely reflective of hepatic (liver) clearance.
  • Combined with data on AP metabolites, pharmacokinetic study of AP could potentially be useful for assessing the activity of the hepatic cytochrome P450 in horses, an enzyme integral to drug metabolism.

Cite This Article

APA
Dyke TM, Sams RA, Hinchcliff KW. (1998). Antipyrine pharmacokinetics and urinary excretion in female horses. Am J Vet Res, 59(3), 280-285.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 59
Issue: 3
Pages: 280-285

Researcher Affiliations

Dyke, T M
  • Analytical Toxicology Laboratory, College of Veterinary Medicine, Ohio State University, Columbus 43210-1089, USA.
Sams, R A
    Hinchcliff, K W

      MeSH Terms

      • Animals
      • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
      • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
      • Anti-Inflammatory Agents, Non-Steroidal / urine
      • Antipyrine / administration & dosage
      • Antipyrine / analogs & derivatives
      • Antipyrine / pharmacokinetics
      • Antipyrine / urine
      • Biotransformation
      • Female
      • Horses
      • Injections, Intravenous
      • Kidney / physiology
      • Metabolic Clearance Rate
      • Time Factors

      Citations

      This article has been cited 0 times.